These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19318028)

  • 1. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome.
    Iversen KK; Teisner AS; Teisner B; Kliem A; Thanning P; Nielsen H; Clemmensen P; Grande P
    Clin Biochem; 2009 Jun; 42(9):828-34. PubMed ID: 19318028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.
    Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Clemmensen P; Grande P
    Am J Cardiol; 2009 Dec; 104(11):1465-71. PubMed ID: 19932776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release patterns of pregnancy-associated plasma protein A in patients with acute coronary syndromes assessed by an optimized monoclonal antibody assay.
    Schoos M; Iversen K; Teisner A; Teisner B; Thaning P; Kliem A; Grande P; Clemmensen P
    Scand J Clin Lab Invest; 2009; 69(1):121-7. PubMed ID: 18855223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction.
    Iversen KK; Teisner AS; Teisner B; Kliem A; Thanning P; Grande P; Clemmensen P
    Am J Cardiol; 2008 May; 101(10):1389-94. PubMed ID: 18471447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI).
    Lund J; Qin QP; Ilva T; Nikus K; Eskola M; Porela P; Kokkala S; Pulkki K; Pettersson K; Voipio-Pulkki LM
    Ann Med; 2006; 38(3):221-8. PubMed ID: 16720436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration.
    Terkelsen CJ; Oxvig C; Nørgaard BL; Glerup S; Poulsen TS; Lassen JF; Møller HJ; Thuesen L; Falk E; Nielsen TT; Andersen HR
    Am J Cardiol; 2009 Jan; 103(1):29-35. PubMed ID: 19101225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS
    Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
    Lopes RD; Pieper KS; Horton JR; Al-Khatib SM; Newby LK; Mehta RH; Van de Werf F; Armstrong PW; Mahaffey KW; Harrington RA; Ohman EM; White HD; Wallentin L; Granger CB
    Heart; 2008 Jul; 94(7):867-73. PubMed ID: 18332062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2009 Jul; 54(4):357-64. PubMed ID: 19608034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Ou FS; Alexander KP; Newby LK; Foody JM; Gibler WB; Boden WE; Ohman EM; Smith SC; Peterson ED
    Eur Heart J; 2008 Oct; 29(20):2480-8. PubMed ID: 18716006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals.
    Roe MT; Chen AY; Delong ER; Boden WE; Calvin JE; Cairns CB; Smith SC; Pollack CV; Brindis RG; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Am Heart J; 2008 Jul; 156(1):185-92. PubMed ID: 18585515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein-A, a marker for outcome in patients suspected for acute coronary syndrome.
    Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Grande P; Clemmensen P
    Clin Biochem; 2010 Jul; 43(10-11):851-7. PubMed ID: 20388505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns and implications of B-type natriuretic peptide measurement in patients with non-ST-segment elevation acute coronary syndromes.
    Atwater BD; Milford-Beland S; Newby LK; Hernandez AF; Peacock WF; Gibler WB; Christenson RH; Ohman EM; Peterson ED; Roe MT
    Am J Cardiol; 2007 Dec; 100(12):1727-33. PubMed ID: 18082516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome.
    Rossen M; Iversen K; Teisner A; Teisner B; Kliem A; Grudzinskas G
    Clin Biochem; 2007 Apr; 40(7):478-84. PubMed ID: 17316591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
    Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Patsourakos NG; Adamopoulou EN; Beldekos DJ; Melidonis AI; Handanis SM; Manolis AJ; Hatzisavvas JJ; Argyrakis SK
    Int J Cardiol; 2008 Mar; 124(3):312-8. PubMed ID: 17433477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal insufficiency increases mortality in acute coronary syndromes regardless of TIMI risk score.
    Dudek D; Chyrchel B; Siudak Z; Depukat R; Chyrchel M; Dziewierz A; Mielecki W; Rakowski T; Rzeszutko Ł; Dubiel J
    Kardiol Pol; 2008 Jan; 66(1):28-34; discussion 35-6. PubMed ID: 18266185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement and clinical significance of circulating PAPP-A in ACS patients.
    Qin QP; Wittfooth S; Pettersson K
    Clin Chim Acta; 2007 May; 380(1-2):59-67. PubMed ID: 17376420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.